Knopp Gives Back
Biogen Idec deal in ALS allows Knopp Neurosciences to issue dividend to investors
Knopp gives back
After licensing its only clinical candidate to Biogen Idec Inc. (NASDAQ:BIIB), Knopp Neurosciences Inc. decided it could afford to give a dividend to investors.
Knopp granted Biogen Idec an exclusive, worldwide license to develop and commercialize dexpramipexole (KNS-760704).The small
